Novel Ventilation Strategies to Reduce Adverse Pulmonary Outcomes

Clin Perinatol. 2022 Mar;49(1):219-242. doi: 10.1016/j.clp.2021.11.019. Epub 2022 Jan 21.

Abstract

Extremely preterm infants who must suddenly support their own gas exchange with lungs that are incompletely developed and lacking adequate amount of surfactant and antioxidant defenses are susceptible to lung injury. The decades-long quest to prevent bronchopulmonary dysplasia has had limited success, in part because of increasing survival of more immature infants. The process must begin in the delivery room with gentle assistance in establishing and maintaining adequate lung aeration, followed by noninvasive support and less invasive surfactant administration. Various modalities of invasive and noninvasive support have been used with varying degree of effect and are reviewed in this article.

Keywords: Bronchopulmonary dysplasia; Less invasive surfactant administration; Lung injury; Mechanical ventilation; Noninvasive respiratory support; Volume-targeted ventilation; Volutrauma.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bronchopulmonary Dysplasia* / drug therapy
  • Humans
  • Infant
  • Infant, Extremely Premature
  • Infant, Newborn
  • Lung
  • Pulmonary Surfactants* / therapeutic use
  • Respiration, Artificial
  • Respiratory Distress Syndrome, Newborn* / etiology
  • Respiratory Distress Syndrome, Newborn* / therapy
  • Surface-Active Agents / therapeutic use

Substances

  • Pulmonary Surfactants
  • Surface-Active Agents